Verdict94/ 100
Ranked #1 · Grade APartner
CoreAge Rx review
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge Rx Partner — we may earn a commission, at no cost to you. It never changes the score.
- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
CoreAge Rx scored on our six published factors. See the methodology.
Real-world results92/100
Price honesty97/100
Prescriber access96/100
Formulary choice88/100
Cancellation fairness95/100
Member support93/100
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the rock-bottom price — budget shoppers can find cheaper teaser tiers elsewhere
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
The verdict
Best for: Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Pricing, states and verification reflect CoreAge Rx's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on CoreAge Rx's site. Not medical advice; see our disclosure.